Related Experiment Video
Updated: Jul 19, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
The pentavalent rotavirus vaccine, RotaTeq
1Graduate Program in Public Health, Eastern Virginia Medical School, Old Dominion University, Norfolk, VA 23501, USA. matsondo@evms.edu
Abstract:
Vaccination against rotavirus disease has been a global preventive health priority since rotaviruses were first discovered in the 1970s. The first licensed rotavirus vaccine, RRV-TV, was removed from the market shortly after licensure because of an unexpected serious adverse event, intussusception. A pentavalent rotavirus vaccine, PRV, is the second FDA-licensed rotavirus vaccine and does not signal the risk observed with RRV-TV. The properties and large safety study results of PRV are reviewed here.
Related Concept Videos
Respiratory Syncytial Virus Disease
Poliomyelitis
Bacterial Gastroenteritis
Vaccinations
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Vaccines
